SEC v. Sai-Hong Ignatius Ou (insider trading, 2024)
Settled
Checked against the primary document on October 3, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, with sampled and disputed records read a second time. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.
In December 2024 the Securities and Exchange Commission charged Sai-Hong Ignatius Ou, a physician and principal investigator in Nuvalent's cancer drug trials, with trading ahead of the October 28, 2022 announcement of positive results, which he learned of in June 2022. Without admitting or denying, he consented, subject to court approval, to an injunction, a five-year officer and director bar, disgorgement of $1,520,455 with interest and an equal penalty.
The record
| Agency | SEC |
|---|---|
| Release number | LR-26198 |
| Date filed | 2024-12-18 |
| Date resolved | 2024-12-18 |
| Court | U.S. District Court, District of Massachusetts |
| Status | settled |
| Asset class | equities |
| Criminal parallel | No |
| Defendants | Sai-Hong Ignatius Ou |
| Cited as charged or alleged | Exchange Act s.10(b) and Rule 10b-5 |
| Techniques | Insider trading |
What was ordered
- Civil penalty
- $1.5m
- Disgorgement
- $1.5m
- Prejudgment interest
- —
- Total relief
- $3m
- Alleged gain
- $1.5m
What is alleged to have happened
The Securities and Exchange Commission announced this matter on December 18, 2024 as release LR-26198, filing in the District of Massachusetts.
The complaint alleges that Ou, as principal investigator at his California university, learned the results would be announced at a conference and traded on that knowledge. The release does not state the amount of the interest.
For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the release.
What technique is this, and how does it work?
This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.
- Insider trading — see how it works, what statute it engages, and every other action tagged the same way.
Timeline
- 2024-12-18 Litigation release published
Primary documents
Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.
Related actions
Other actions in the library sharing at least one technique tag with this one.
| Action | Agency | Filed | Technique | Penalty | Status |
|---|---|---|---|---|---|
| SEC v. Trijya Vakil and Neeraj Visen (insider trading, 2026) | SEC | 2026-09-04 | Insider Trading | $109k | settled |
| CFTC v. Gabriel Perez (insider trading, 2026) | CFTC | 2026-08-28 | Insider Trading | $65k | judgment |
| SEC v. Gavin Wolfe and others (insider trading, 2026) | SEC | 2026-08-21 | Insider Trading | — | filed |
| SEC v. Jesse R. Mitchell (insider trading, 2026) | SEC | 2026-08-21 | Insider Trading | — | filed |
| SEBI v. Arun Kumar Somani and others (insider trading review, Indian Oil Corporation, 2026) | SEBI (India) | 2026-08-13 | Insider Trading | — | dismissed |
| SEC v. Benjamin Tesfaye (insider trading, 2026) | SEC | 2026-08-11 | Insider Trading | $18.7k | settled |